BR112012025172A2 - células de ilhotas gabaritadas e agrupamentos de células de ilhotas pequenas para tratamento de diabetes. - Google Patents
células de ilhotas gabaritadas e agrupamentos de células de ilhotas pequenas para tratamento de diabetes.Info
- Publication number
- BR112012025172A2 BR112012025172A2 BR112012025172A BR112012025172A BR112012025172A2 BR 112012025172 A2 BR112012025172 A2 BR 112012025172A2 BR 112012025172 A BR112012025172 A BR 112012025172A BR 112012025172 A BR112012025172 A BR 112012025172A BR 112012025172 A2 BR112012025172 A2 BR 112012025172A2
- Authority
- BR
- Brazil
- Prior art keywords
- islet
- cell clusters
- templateed
- small
- treating diabetes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
- C12N5/0677—Three-dimensional culture, tissue culture or organ culture; Encapsulated cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/39—Pancreas; Islets of Langerhans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
- A61L27/3882—Hollow organs, e.g. bladder, esophagus, urether, uterus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
- A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
- A61L27/3895—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells using specific culture conditions, e.g. stimulating differentiation of stem cells, pulsatile flow conditions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0676—Pancreatic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/40—Polyhydroxyacids, e.g. polymers of glycolic or lactic acid (PGA, PLA, PLGA); Bioresorbable polymers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2535/00—Supports or coatings for cell culture characterised by topography
- C12N2535/10—Patterned coating
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Biochemistry (AREA)
- Developmental Biology & Embryology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Diabetes (AREA)
- Virology (AREA)
- Nutrition Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Physiology (AREA)
- Immunology (AREA)
- Vascular Medicine (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Endocrinology (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/798,529 US8735154B2 (en) | 2006-10-30 | 2010-04-06 | Templated islet cells and small islet cell clusters for diabetes treatment |
PCT/US2011/030775 WO2011126921A2 (en) | 2010-04-06 | 2011-03-31 | Templated islet cells and small islet cell clusters for diabetes treatment |
Publications (2)
Publication Number | Publication Date |
---|---|
BR112012025172A2 true BR112012025172A2 (pt) | 2017-06-27 |
BR112012025172B1 BR112012025172B1 (pt) | 2018-08-28 |
Family
ID=44515145
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112012025172A BR112012025172B1 (pt) | 2010-04-06 | 2011-03-31 | células de ilhotas gabaritadas e agrupamentos de células de ilhotas pequenas para tratamento de diabetes. |
Country Status (10)
Country | Link |
---|---|
US (2) | US8735154B2 (pt) |
EP (1) | EP2555807B9 (pt) |
JP (1) | JP5956422B2 (pt) |
CN (1) | CN102958543B (pt) |
AU (1) | AU2011238540B2 (pt) |
BR (1) | BR112012025172B1 (pt) |
CA (1) | CA2795243C (pt) |
DK (1) | DK2555807T5 (pt) |
MX (1) | MX2012011644A (pt) |
WO (1) | WO2011126921A2 (pt) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8735154B2 (en) * | 2006-10-30 | 2014-05-27 | The University Of Kansas | Templated islet cells and small islet cell clusters for diabetes treatment |
EP2286822A1 (en) | 2009-08-17 | 2011-02-23 | Universiteit Twente | Diabetes treatment |
US8895048B2 (en) | 2010-04-06 | 2014-11-25 | The University Of Kansas | Templated islet cells and small islet cell clusters for diabetes treatment |
WO2013016544A2 (en) * | 2011-07-27 | 2013-01-31 | University Of Kansas | Templated islet cells and small islet cell clusters for diabetes treatment |
WO2013156855A1 (en) * | 2012-04-20 | 2013-10-24 | Biolamina Ab | Maintenance of differentiated cells with laminins |
US20150320836A1 (en) * | 2012-07-06 | 2015-11-12 | The Regents Of The University Of California | Cryopreservation of cells inside a macro-encapsulation device |
JP6145257B2 (ja) * | 2012-10-18 | 2017-06-07 | 株式会社クラレ | エストロゲン活性を評価する方法 |
DK2909311T3 (da) | 2012-10-18 | 2020-10-12 | Univ Kansas | Forbedret pålidelighed hos tests under anvendelse af en platform med flere fordybninger og flercellede klynger med flere kilder |
KR102181336B1 (ko) | 2013-06-13 | 2020-11-24 | 오르제네시스 엘티디. | 세포 집단, 이의 전환분화 방법 및 이용 방법 |
CA2923504A1 (en) * | 2013-09-19 | 2015-03-26 | Beta-Cell Nv | Method for the treatment of diabetes mellitus |
US10092550B2 (en) | 2014-10-21 | 2018-10-09 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing curcumin, harmine, and isovanillin components, and methods of use thereof |
ES2744913T3 (es) | 2014-10-21 | 2020-02-26 | Ankh Life Sciences Ltd | Agentes terapéuticos humanos |
US9907786B2 (en) | 2014-10-21 | 2018-03-06 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions containing harmine and isovanillin components, and methods of use thereof |
WO2016181220A2 (en) | 2015-05-13 | 2016-11-17 | Ions Pharmaceutical S.À R.L. | Therapeutic compositions and methods of use thereof |
US20160106687A1 (en) | 2014-10-21 | 2016-04-21 | Life Plus, LLC | Human therapeutic agents |
EP3455345B1 (en) | 2016-05-11 | 2021-03-24 | Animal Cell Therapy - Act | Production of a canine beta cell line from an immature pancreas |
US10597639B2 (en) | 2016-10-20 | 2020-03-24 | Washington University | 3D-printed scaffold device for cell transplantation |
US10767164B2 (en) | 2017-03-30 | 2020-09-08 | The Research Foundation For The State University Of New York | Microenvironments for self-assembly of islet organoids from stem cells differentiation |
SG11201911256UA (en) | 2017-05-08 | 2020-01-30 | Orgenesis Ltd | Transdifferentiated cell populations and methods of use thereof |
EP3630135A4 (en) * | 2017-05-29 | 2021-03-03 | Orgenesis Ltd. | COMPOSITIONS AND METHOD OF PROVIDING CELL REPLACEMENT THERAPY |
US20210369788A1 (en) | 2017-11-08 | 2021-12-02 | Animal Cell Therapy - Act | Production of canine pancreatic islets from an immature pancreas |
CN111269873A (zh) * | 2018-12-05 | 2020-06-12 | 中国科学院大连化学物理研究所 | 一种基于微坑芯片的3d胰岛细胞血管化微球构建方法 |
CN114870093B (zh) * | 2022-05-07 | 2023-04-07 | 四川大学 | 基于数字光处理的3d打印组织工程胰岛及其制备方法和用途 |
Family Cites Families (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK402984D0 (da) | 1984-08-23 | 1984-08-23 | Nordisk Insulinlab | Fremgangsmaade til formering af insulin-producerende celler |
EP0363125A3 (en) | 1988-10-03 | 1990-08-16 | Hana Biologics Inc. | Proliferated pancreatic endocrine cell product and process |
US5164000A (en) | 1991-06-27 | 1992-11-17 | Gamblin Rodger L | Lithographic printing fountain solution |
US5280038A (en) | 1992-03-13 | 1994-01-18 | Virginia Commonwealth University | Histidine as a protective agent in cardiac surgery and myocardial ischemic syndrome |
US5696109A (en) | 1992-12-07 | 1997-12-09 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5510263A (en) | 1993-04-05 | 1996-04-23 | Desmos, Inc. | Growth of pancreatic islet-like cell clusters |
US6703017B1 (en) | 1994-04-28 | 2004-03-09 | Ixion Biotechnology, Inc. | Reversal of insulin-dependent diabetes by islet-producing stem cells, islet progenitor cells and islet-like structures |
US5681587A (en) | 1995-10-06 | 1997-10-28 | Desmos, Inc. | Growth of adult pancreatic islet cells |
US5965125A (en) | 1995-10-25 | 1999-10-12 | Transkaryotic Therapies, Inc. | Hybrid matrix implants and explants |
US5670545A (en) | 1996-02-09 | 1997-09-23 | Board Of Regents Of The University Of Colorado | Method for the treatment of ischemic disease and reperfusion injury and the prevention of the adverse effects of reactive oxygen species |
DE69841937D1 (de) | 1997-04-21 | 2010-11-25 | California Inst Of Techn | Multifunctionelle polymer-beschichtung |
US7282240B1 (en) * | 1998-04-21 | 2007-10-16 | President And Fellows Of Harvard College | Elastomeric mask and use in fabrication of devices |
US6783954B2 (en) | 1999-03-05 | 2004-08-31 | Compugen Ltd. | VEGF nucleic acid and amino acid sequences |
US6365385B1 (en) | 1999-03-22 | 2002-04-02 | Duke University | Methods of culturing and encapsulating pancreatic islet cells |
US6699470B1 (en) | 1999-10-12 | 2004-03-02 | Massachusetts Institute Of Technology | Mesh-gel constructs for cell delivery containing enzymes and/or enzyme inhibitors to control gel degradation |
US6734000B2 (en) * | 2000-10-12 | 2004-05-11 | Regents Of The University Of California | Nanoporous silicon support containing macropores for use as a bioreactor |
US7786257B2 (en) | 2000-12-18 | 2010-08-31 | University Of Kansas | Signal-1/signal-2 bifunctional peptide inhibitors |
WO2002092778A2 (en) * | 2001-05-17 | 2002-11-21 | The Board Of Trustees Of The Leland Stanford Junior University | Device and method for three-dimensional spatial localization and functional interconnection of different types of cells |
AU2002352696A1 (en) | 2001-11-16 | 2003-06-10 | University Of North Carolina At Chapel Hill | Cell substrates and methods of use thereof |
US20040175366A1 (en) | 2003-03-07 | 2004-09-09 | Acell, Inc. | Scaffold for cell growth and differentiation |
US20080220520A1 (en) * | 2003-11-19 | 2008-09-11 | Palecek Sean P | Cryopreservation of human embryonic stem cells in microwells |
US20070266801A1 (en) * | 2005-12-16 | 2007-11-22 | Alireza Khademhosseini | Reversible Sealing of Microfluidic Arrays |
CN101336290B (zh) * | 2005-12-30 | 2013-03-13 | 药物模式有限责任公司 | 用于细胞和组织培养的生物反应器 |
CA2637663C (en) * | 2006-01-24 | 2015-06-02 | Brown University | Cell aggregation and encapsulation device and method |
CN101121930A (zh) * | 2006-08-11 | 2008-02-13 | 国家纳米科学中心 | 将多种细胞粘附到同一基底上的装置及粘附方法 |
US8735154B2 (en) * | 2006-10-30 | 2014-05-27 | The University Of Kansas | Templated islet cells and small islet cell clusters for diabetes treatment |
US20080103606A1 (en) | 2006-10-30 | 2008-05-01 | Cory Berkland | Templated islet cells and small islet cell clusters for diabetes treatment |
JP4963975B2 (ja) * | 2007-01-23 | 2012-06-27 | 大阪瓦斯株式会社 | 廃水処理方法 |
CN101815782B (zh) * | 2007-09-12 | 2014-02-05 | 公益财团法人北九州产业学术推进机构 | 细胞培养器具和使用该器具的细胞培养方法 |
EP2286822A1 (en) | 2009-08-17 | 2011-02-23 | Universiteit Twente | Diabetes treatment |
-
2010
- 2010-04-06 US US12/798,529 patent/US8735154B2/en active Active
-
2011
- 2011-03-31 JP JP2013503797A patent/JP5956422B2/ja not_active Expired - Fee Related
- 2011-03-31 MX MX2012011644A patent/MX2012011644A/es active IP Right Grant
- 2011-03-31 BR BR112012025172A patent/BR112012025172B1/pt not_active IP Right Cessation
- 2011-03-31 DK DK11714194.5T patent/DK2555807T5/da active
- 2011-03-31 AU AU2011238540A patent/AU2011238540B2/en not_active Ceased
- 2011-03-31 EP EP11714194.5A patent/EP2555807B9/en active Active
- 2011-03-31 WO PCT/US2011/030775 patent/WO2011126921A2/en active Application Filing
- 2011-03-31 CA CA2795243A patent/CA2795243C/en active Active
- 2011-03-31 CN CN201180018047.5A patent/CN102958543B/zh not_active Expired - Fee Related
-
2014
- 2014-04-09 US US14/249,016 patent/US20140219997A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
BR112012025172B1 (pt) | 2018-08-28 |
AU2011238540B2 (en) | 2014-12-04 |
DK2555807T3 (da) | 2019-11-11 |
EP2555807B9 (en) | 2021-12-08 |
US20100233239A1 (en) | 2010-09-16 |
WO2011126921A2 (en) | 2011-10-13 |
JP2013524787A (ja) | 2013-06-20 |
CA2795243A1 (en) | 2011-10-13 |
CA2795243C (en) | 2019-06-11 |
US20140219997A1 (en) | 2014-08-07 |
US8735154B2 (en) | 2014-05-27 |
WO2011126921A3 (en) | 2012-01-19 |
MX2012011644A (es) | 2013-02-11 |
DK2555807T5 (da) | 2022-01-03 |
JP5956422B2 (ja) | 2016-07-27 |
AU2011238540A1 (en) | 2012-11-29 |
CN102958543B (zh) | 2016-01-13 |
CN102958543A (zh) | 2013-03-06 |
EP2555807A2 (en) | 2013-02-13 |
EP2555807B1 (en) | 2019-07-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112012025172A2 (pt) | células de ilhotas gabaritadas e agrupamentos de células de ilhotas pequenas para tratamento de diabetes. | |
IL225923B (en) | Cell culture material derived from a plant, methods for its preparation and uses thereof | |
JP2012140442A5 (pt) | ||
BRPI1009981A2 (pt) | sistemas , métodos e composições para otimizar os enxertos enriquecidos de tecido e célula | |
EA201201648A1 (ru) | Стимуляторы sgc | |
MX2013000917A (es) | Metodos para detectar las enfermedades o condiciones usando celulas fagociticas. | |
DOP2011000384A (es) | Metodos para el cultivo de celulas madre y progenitoras | |
ZA201408643B (en) | Gas-steam efficient cogeneration process and system based on biomass gasification and methanation | |
CL2013000052A1 (es) | Proceso para la produccion de lignina precipitada a partir de licor negro; lignina precipitada; solucion que comprende a dicha lignina precipitada; y uso de dicha lignina precipitada. | |
BR112013015058A2 (pt) | micro-organismos e métodos para a produção de 1,4-ciclo-hexanodimetanol | |
NO20081642L (no) | Kraftverk, fremgangsmåte for kraftproduksjon, samt anvendelse av kraftverket. | |
ZA201304187B (en) | A hydrogen-producing cell comprising a cell of a high temperature steam electrolyzer | |
EP2557625A4 (en) | METHOD FOR MANUFACTURING A SEALED STRUCTURE FOR A BIPOLAR BATTERY, METHOD FOR MANUFACTURING A BIPOLAR BATTERY, SEALED STRUCTURE FOR A BIPOLAR BATTERY, AND BIPOLAR BATTERY | |
EP2384312A4 (en) | WATER AGGREGATES, PRODUCTS HAVING WATER AGGREGATES AND PROCESSES FOR PRODUCING | |
BR112013015396A2 (pt) | método para a preparação de 18f para uso em uma hreação de radiofluoração, reação de radiofluoração e cassete para a realização da reação de radiofluoração | |
ZA201005208B (en) | Process for the manufacture of solar cells | |
HUE037001T2 (hu) | Eljárás egy adott metabolitot a megfelelõ vad típushoz képest megnövelt koncentrációban tartalmazó sejt azonosítására, ahol a sejt rekombináns mérnökség (rekombineering) révén van módosítva; eljárás egy adott metabolit optimális termelésével bíró, genetikailag módosított sejt elõállítására; eljárás az említett metabolit és a megfelelõ nukleinsavak elõállítására | |
PL2552401T3 (pl) | Zastosowanie preparatu otrzymanego z hodowli in vitro odróżnicowanych nieelicytowanych komórek drzewa arganowego, do leczenia starzenia się skóry | |
DK3342867T3 (da) | Xylanasemutant, fremgangsmåde til fremstilling og anvendelse herfor, og fremgangsmåde til fremstilling af forsukret lignocellulose | |
BR112013011417A2 (pt) | microrganismos para a produção de 1,3-propanodiol usando alta concentração de glicerina | |
WO2011159693A3 (en) | Oral treatment of digital ischemic lesions | |
BR112013010831A2 (pt) | método para fabricar células solares, atenuando os fenômenos de lid | |
HUE038546T2 (hu) | Száraz helyiség, különösen lítium-ion cellagyártásnál történõ alkalmazásra | |
IL211567A0 (en) | Use of stem cells to prevent neuronal dieback | |
BR112012025490A2 (pt) | ''método para produção de 1,5 oebtanodiamina'' |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B07B | Technical examination (opinion): publication cancelled [chapter 7.2 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 31/03/2011, OBSERVADAS AS CONDICOES LEGAIS. |
|
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 12A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2716 DE 24-01-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |